corpus.blog
41554 blogs · [ { "id": "01a0875e-1bb1-7222-9d70-4625d5f65188", "title": "Why CUE-221 Might Not Beat Omalizumab In CSU And Could Still Separate In Food Allergy", "url": "https://www.chaotropy.com/why-cue-221-might-not-beat-omalizumab-in-csu-and-could-still-separate-in-food-allergy/", "published_at": "2026-08-27T15:55:37+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625d65a3982", "title": "Non-Physical Intelligence Has A Ceiling", "url": "https://www.chaotropy.com/non-physical-intelligence-has-a-ceiling/", "published_at": "2026-08-09T15:34:34+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625d6bb203a", "title": "Early Results Of Verastem's VS-7375 In Pancreatic Cancer, Or How To Read A Reduction In CA19-9", "url": "https://www.chaotropy.com/early-results-of-verastems-vs-7375-in-pancreatic-cancer-or-how-to-read-a-reduction-in-ca19-9/", "published_at": "2026-07-19T15:56:26+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625d7b606c0", "title": "Palantir Is Building The \"Brain of The Firm\" Envisioned Half a Century Ago", "url": "https://www.chaotropy.com/palantir-is-building-the-brain-of-the-firm-envisioned-half-a-century-ago/", "published_at": "2026-07-05T16:26:16+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625d80f550e", "title": "Innovation: America's Perpetual Frontier", "url": "https://www.chaotropy.com/americas-perpetual-frontier/", "published_at": "2026-07-04T15:43:18+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625d8635ca7", "title": "Nektar's Rezpegaldesleukin: Aiming To Restore Peripheral Immune Balance", "url": "https://www.chaotropy.com/nektars-rezpegaldesleukin-aiming-to-restore-peripheral-immune-balance/", "published_at": "2026-06-14T14:36:24+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625d8f66ab4", "title": "Why Licensing A Dual-Mechanism Anti-IgE Antibody Could Be A Major Opportunity For Cue Biopharma", "url": "https://www.chaotropy.com/why-licensing-a-dual-mechanism-anti-ige-antibody-could-be-a-major-opportunity-for-cue-biopharma/", "published_at": "2026-05-17T15:01:09+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625d9c6dc63", "title": "Mufemilast Phase 2 Data May Partially De-Risk Palisade Bio's PALI-2108", "url": "https://www.chaotropy.com/mufemilast-phase-2-data-may-partially-de-risk-palisade-bios-pali-2108/", "published_at": "2026-05-04T16:06:36+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625d9ef69ce", "title": "A Nature Medicine Paper Linking Picloram To Early-Onset Colorectal Cancer Leaves An Open Question", "url": "https://www.chaotropy.com/a-nature-medicine-paper-linking-picloram-to-early-onset-colorectal-cancer-leaves-an-open-question/", "published_at": "2026-04-26T18:59:09+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625da51bcd4", "title": "Computational Simulation Of Four Non-Covalent KRAS G12D Inhibitors Suggests Verastem's VS-7375 May Achieve The Deepest Signaling Suppression", "url": "https://www.chaotropy.com/computational-simulation-of-four-non-covalent-kras-g12d-inhibitors-suggests-verastems-vs-7375-may-achieve-the-deepest-signaling-suppression/", "published_at": "2026-04-24T16:08:55+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625db095d96", "title": "Phase 3 Readout Of Daraxonrasib In 2L Metastatic PDAC Marks An Inflection Point For Pancreatic Cancer", "url": "https://www.chaotropy.com/phase-3-readout-of-daraxonrasib-in-2l-metastatic-pdac-marks-an-inflection-point-for-pancreatic-cancer/", "published_at": "2026-04-18T13:55:59+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625db55cb70", "title": "Revisiting My PALI-2108 Tissue Penetration Model In Fibrostenotic Crohn's Disease After Phase 1b Readout", "url": "https://www.chaotropy.com/revisiting-my-pali-2108-tissue-penetration-model-in-fibrostenotic-crohns-disease-after-phase-1b-readout/", "published_at": "2026-04-05T19:00:00+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625dba2d0bf", "title": "Pharmacokinetic Simulation Of Tenax's Oral Levosimendan Suggests Higher Drug Exposure Than IV Dosing In PH-HFpEF", "url": "https://www.chaotropy.com/pharmacokinetic-simulation-of-tenaxs-oral-levosimendan-suggests-higher-drug-exposure-than-iv-dosing-in-ph-hfpef/", "published_at": "2026-03-22T14:54:55+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625dc07d33d", "title": "Johns Hopkins mKRAS Vaccine Trial Strengthens The Case For Elicio's ELI-002", "url": "https://www.chaotropy.com/johns-hopkins-mkras-vaccine-trial-strengthens-the-case-for-elicios-eli-002/", "published_at": "2026-03-09T18:02:05+00:00" }, { "id": "01a0875e-1bb1-7222-9d70-4625dcf1deff", "title": "Monte Carlo Simulation Of Elicio's Phase II AMPLIFY-7P Study Favors Vaccine Efficacy", "url": "https://www.chaotropy.com/monte-carlo-simulation-of-elicios-phase-ii-amplify-7p-study-favors-vaccine-efficacy/", "published_at": "2026-03-01T13:24:23+00:00" } ] posts Claim your blog
Back to chaotropy.com
Blog · corpus.blog/blogs/chaotropy.com/posts

chaotropy.com

chaotropy.com

2026

Why CUE-221 Might Not Beat Omalizumab In CSU And Could Still Separate In Food Allergyoriginal ↗
27 Aug 2026
Non-Physical Intelligence Has A Ceilingoriginal ↗
9 Aug 2026
Early Results Of Verastem's VS-7375 In Pancreatic Cancer, Or How To Read A Reduction In CA19-9original ↗
19 Jul 2026
Palantir Is Building The "Brain of The Firm" Envisioned Half a Century Agooriginal ↗
5 Jul 2026
Innovation: America's Perpetual Frontieroriginal ↗
4 Jul 2026
Nektar's Rezpegaldesleukin: Aiming To Restore Peripheral Immune Balanceoriginal ↗
14 Jun 2026
Why Licensing A Dual-Mechanism Anti-IgE Antibody Could Be A Major Opportunity For Cue Biopharmaoriginal ↗
17 May 2026
Mufemilast Phase 2 Data May Partially De-Risk Palisade Bio's PALI-2108original ↗
4 May 2026
A Nature Medicine Paper Linking Picloram To Early-Onset Colorectal Cancer Leaves An Open Questionoriginal ↗
26 Apr 2026
Computational Simulation Of Four Non-Covalent KRAS G12D Inhibitors Suggests Verastem's VS-7375 May Achieve The Deepest Signaling Suppressionoriginal ↗
24 Apr 2026
Phase 3 Readout Of Daraxonrasib In 2L Metastatic PDAC Marks An Inflection Point For Pancreatic Canceroriginal ↗
18 Apr 2026
Revisiting My PALI-2108 Tissue Penetration Model In Fibrostenotic Crohn's Disease After Phase 1b Readoutoriginal ↗
5 Apr 2026
Pharmacokinetic Simulation Of Tenax's Oral Levosimendan Suggests Higher Drug Exposure Than IV Dosing In PH-HFpEForiginal ↗
22 Mar 2026
Johns Hopkins mKRAS Vaccine Trial Strengthens The Case For Elicio's ELI-002original ↗
9 Mar 2026
Monte Carlo Simulation Of Elicio's Phase II AMPLIFY-7P Study Favors Vaccine Efficacyoriginal ↗
1 Mar 2026